Humalog and Levitra drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Levitra (vardenafil hydrochloride). Common drug interactions include chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Humalog and Levitra. It is created by eHealthMe based on reports of 89 people who take the same drugs from the FDA, and is updated regularly.
What is Humalog?
Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.
What is Levitra?
Levitra has active ingredients of vardenafil hydrochloride. It is often used in erection problems. eHealthMe is studying from 10,392 Levitra users. Check the latest studies of Levitra.
89 people who take Humalog and Levitra together, and have interactions are studied.

What are the common drug interactions of Humalog and Levitra, by gender? *:
female:
n/a
male:
- Chronic kidney disease
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cardiac failure congestive
- Diarrhoea
- Dyspnoea (difficult or laboured respiration)
- Emotional distress
- Infection
- Insomnia (sleeplessness)
- International normalised ratio increased
What are the common drug interactions of Humalog and Levitra, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Diarrhoea
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Renal injury (kidney injury)
- Urinary tract infection
- Urinary tract obstruction
40-49:
- Acute myocardial infarction (acute heart attack)
- Cardiac failure congestive
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Diastolic dysfunction
- Flushing (the warm, red condition of human skin)
- Headache (pain in head)
- Pleural effusion (water on the lungs)
- Adverse event
- Burning sensation
50-59:
- Asthenia (weakness)
- Back pain
- Blood cholesterol increased
- Bone disorder
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cardiac failure congestive
- Cardiac valve abscess (pus containing infection of heart valve)
- Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
- Conjunctivitis (pink eye)
- Constipation
60+:
- Chronic kidney disease
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Arteriosclerosis (thickening and hardening of arteries)
- Arthralgia (joint pain)
- Cardiac failure congestive
- Dyspnoea (difficult or laboured respiration)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Infection
- Insomnia (sleeplessness)
- International normalised ratio increased
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 22 people, 24.72%
- Pain: 17 people, 19.10%
- Multiple Myeloma (cancer of the plasma cells): 15 people, 16.85%
- High Blood Pressure: 15 people, 16.85%
- Type 2 Diabetes: 10 people, 11.24%
- High Blood Cholesterol: 10 people, 11.24%
- Cardiac Disorder: 9 people, 10.11%
- Infection: 7 people, 7.87%
- Hypersensitivity: 6 people, 6.74%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 5.62%
* Approximation only. Some reports may have incomplete information.
Do you take Humalog and Levitra?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Humalog and Levitra:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Humalog:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Levitra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Humalog and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Levitra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on insulin lispro recombinant and vardenafil hydrochloride (the active ingredients of Humalog and Levitra, respectively), and Humalog and Levitra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Latanoprost cause Hyperkalemia? - now
- Could Atenolol cause Cardiac Death? - 12 seconds ago
- Could Flecainide Acetate cause Hypertension Aggravated? - 23 seconds ago
- Pulmonary Tuberculosis Aggravated and Bleeding Disorders - 24 seconds ago
- Drug interactions of Oxybutynin and Synthroid - 25 seconds ago
- Drug interactions of Velban and Decadron - 29 seconds ago
- Could Armour Thyroid cause Neoplasm Progression? - 36 seconds ago
- Could Bydureon cause Dizziness? - 46 seconds ago
- Faecal Incontinence and drugs of ingredients of prochlorperazine - 57 seconds ago
- Profen and Fentanyl drug interactions for men aged 50-59 - a minute ago